
Tyra Biosciences Investor Relations Material
Latest events

Study Update
Tyra Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tyra Biosciences Inc
Access all reports
Tyra Biosciences Inc. is a clinical-stage biotechnology company specializing in the development of precision medicines targeted at Fibroblast Growth Factor Receptor biology. Leveraging its proprietary platform, Tyra Biosciences focuses on creating drugs through iterative molecular snapshots which aid in predicting genetic alterations and developing therapies for oncology and genetically defined conditions. The company is headquartered in Carlsbad, California, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
TYRA
Country
🇺🇸 United States